Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
How will vaccine and therapeutic makers respond to the new SARS-CoV-2 variant?
Exploring the potential of vaccines for treatment equity.
The EMA has given the nod to Ronapreve and Regkirona, two monoclonal antibody treatments for COVID-19.
How RNA is making waves in the industry – and leading to new research projects and increased demand for new manufacturing capacities.
Setting its sights on self-amplifying RNA, AstraZeneca has signed a deal with Imperial College London spinoff VaxEquity.
The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.
Part 2 of our roundtable discussion with CDMOs covers outsourcing preferences, the demand for mRNA, and more.
The way the pharma industry has traditionally handled clinical trials does not make participation easy.
What lessons were learned from Operation Warp Speed?
Meet the international coalition working to tackle COVID-19 in low- and middle-income countries.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
Painted Cells and Scrambled Jigsaws
The Time is Now for Digitally Simplified Bioprocessing
ADCs: Still Room for Improvement!